Ustekinumab for moderately to severely active Crohn’s disease after previous treatment

Final appraisal determination

Final appraisal determination document (PDF 440 KB)

Committee papers (PDF 19.14 MB)

Public committee slides (PDF 460 KB)

Public committee slides (PDF 458 KB)

Final appraisal determination document Equality Impact Assessment (PDF 223 KB)

Final appraisal determination document 2nd Final appraisal determination (PDF 444 KB)

Final scope (PDF 171 KB)

Final matrix (PDF 153 KB)

Draft scope and provisional matrix comments table (post-referral) (PDF 214 KB)

Equality impact assessment (Scoping) (PDF 121 KB)